Comparison
Gimme vs Hims
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| Gimme | Hims | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | from $163/mo (3-mo prepay) | Not tracked |
| Semaglutide price | from $130/mo (3-mo prepay) | from $199/mo (12-mo prepay) |
| Pharmacy receipt | Fills through Align Pharmacy, Apothecary Pharma +4 per market data — Apothecary Pharma, BPI Labs are FDA-registered 503B outsourcing facilities (federal cGMP oversight). Pick your state to check the rest. | Names its pharmacy (Strive Pharmacy, Curexa +1) — Strive Pharmacy, RedRock Pharmacy state-verified by us in up to 17 states. Pick your state to check yours. |
| Care receipt | Care is outsourced to Bask Telehealth — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. | Care is outsourced to You Health — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. |
| Review integrity | Review-integrity flag — 89% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. | Review-integrity flag — 72% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. |
| Company address | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | 50 states | In review |
| Pharmacy model | Telehealth platform that connects patients with licensed prescribers and routes prescriptions to compounding pharmacies for fulfillment. Sells compounded semaglutide and compounded tirzepatide (injectable). The site states these are made by 'highly regulated' U.S. pharmacies but that 'the FDA has not evaluated the medications for safety, quality, or efficacy.' Brand products (Mounjaro, Zepbound) are noted as not compounded. | Hims is unusually vertically integrated for a GLP-1 telehealth brand: Hims & Hers Health, Inc. owns and operates its own pharmacy and manufacturing chain rather than only contracting out. Per its FY2025 Form 10-K, the company operates two licensed 503A mail-order pharmacies that fill solely for its own customers - Apostrophe Pharmacy LLC and XeCare, LLC, both now wholly-owned subsidiaries - plus a licensed 503B outsourcing facility, MedisourceRx (acquired September 2024 as Seaview Enterprises, LLC, for $31.0 million; Los Alamitos, CA), which compounded its injectable semaglutide, and a peptide manufacturing facility. The consumer Terms also name third-party partner pharmacies (EHT Pharmacy LLC dba Curexa, CD Pharmacy LLC dba Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties, Inc.). During the April-June 2025 Novo Nordisk bundle, brand-name Wegovy was dispensed through Novo's own NovoCare Pharmacy accessed via the Hims platform. Prescriptions are written by providers in affiliated 'You Health' professional medical groups; Hims & Hers states in its Terms that it is not itself a healthcare provider. |
| Red flags on file | 2 | 5 |
Visit gimme.care
Plain link, not sponsored — we take no payment for this.
Visit hims.com
Plain link, not sponsored — we take no payment for this.
Full profiles: Gimme → · Hims →
State-aware license reads: the tirzepatide price board →